A Study of Galunisertib in Participants With Myelodysplastic Syndromes

Clinical trial NCT02008318 · COMPLETED

Trial details

NCT number: NCT02008318
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2014-03-01
Primary completion: 2016-03-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.